五洲医疗股价涨5.21%，诺安基金旗下1只基金位居十大流通股东，持有32.79万股浮盈赚取78.37万元

Company Overview - Wuzhou Medical, established on April 15, 2011, is located in Anqing City, Anhui Province, and specializes in the research, production, and sales of disposable sterile infusion medical devices and related medical supplies [1] - The company went public on July 5, 2022, and has a current market capitalization of 3.281 billion yuan [1] - Main business revenue composition includes: syringes 41.29%, medical puncture needles 25.51%, infusion and blood transfusion devices 20.92%, and others 12.28% [1] Stock Performance - On September 19, Wuzhou Medical's stock rose by 5.21%, reaching 48.25 yuan per share, with a trading volume of 60.1834 million yuan and a turnover rate of 1.91% [1] Shareholder Information - Noan Fund's Noan Multi-Strategy Mixed A (320016) is among the top ten circulating shareholders of Wuzhou Medical, having increased its holdings by 181,600 shares in the second quarter, totaling 327,900 shares, which represents 1.78% of the circulating shares [2] - The fund has achieved a year-to-date return of 59.64% and a one-year return of 124.24% [2] Fund Management - The fund manager of Noan Multi-Strategy Mixed A is Kong Xianzheng, who has been in the position for 4 years and 298 days, with a total fund asset size of 4.607 billion yuan [3] - The best and worst fund returns during Kong's tenure are 77.68% and -16.74%, respectively [3] - Co-manager Wang Haichang has been in the role for 3 years and 60 days, managing assets of 2.529 billion yuan, with best and worst returns of 65.18% and -18.8% [3]